ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Biomea Fusion, Inc. Investors to Inquire About Securities Class Action Investigation – BMEA

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Biomea Fusion, Inc. (NASDAQ: BMEA) resulting from allegations that Biomea Fusion may have issued materially misleading business information to the investing public. WHAT IS THIS ABOUT: On June 6, 2024, after the market closed, Biomea Fusion issued a press release entitled "Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold." It stated that the company had ...